Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0081 | 0.2255 | 1 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0025 | 0.0281 | 0.1145 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0281 | 0.0281 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0025 | 0.0281 | 0.1028 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0094 | 0.2737 | 1 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0086 | 0.2456 | 0.2456 |
Loa Loa (eye worm) | hypothetical protein | 0.0299 | 1 | 1 |
Brugia malayi | Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog | 0.0025 | 0.0281 | 0.1145 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0081 | 0.2255 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0299 | 1 | 0.5 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0086 | 0.2456 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0299 | 1 | 1 |
Echinococcus granulosus | voltage gated potassium channel | 0.0025 | 0.0281 | 0.1145 |
Loa Loa (eye worm) | inward rectifying k channel family protein 1 | 0.0299 | 1 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0094 | 0.2737 | 1 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0025 | 0.0281 | 0.1145 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0025 | 0.0281 | 0.1028 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.2052 | 0.2052 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0086 | 0.2456 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0086 | 0.2456 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0025 | 0.0281 | 0.1145 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.